Glucocorticoids remain the basis for treatment of myasthenia gravis in the era of targeted therapies
Hai-feng LI
Chinese Journal of Contemporary Neurology and Neurosurgery . 2024, (5): 295 -307 .  DOI: 10.3969/j.issn.1672-6731.2024.05.001